Semi-annual Report for 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Semi-annual Report for 2026
Filed with SSE ·
6ix hasn’t read this filing yet.
Wuhan Healthgen Biotechnology Corp on 6ix
Earlier from Wuhan Healthgen Biotechnology
- Announcement on Listing and Trading of Certain Restricted Shares from Offline Placement in the Initial Public Offering
- Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction and 2025 Annual Performance Briefing
- Announcement on Wholly-owned Subsidiary Opening Special Account for Raised Funds and Signing Supervision Agreement
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
- Announcement on Resolutions of the 2025 Annual General Meeting
Later from Wuhan Healthgen Biotechnology
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
- "WUHAN HEALTHGEN BIOTECHNOLOGY CORP."2026 Semi-annual Continuous Supervision and Guidance Follow-up Report of GUOTAI HAITONG SECURITIES CO., LTD. on WUHAN HEALTHGEN BIOTECHNOLOGY CORP.
- Announcement on Pledge and Release of Pledge of Certain Shares Held by Shareholder Holding More Than 5% of the Shares
- (688765)"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Announcement on Listing and Trading of Certain Restricted Shares from the Initial Public Offering and Certain Restricted Shares from the Strategic Placement
- (688765)"WUHAN HEALTHGEN BIOTECHNOLOGY CORP."Announcement on Use of Certain Idle Raised Funds (Including Over-raised Funds) for Cash Management
Follow Wuhan Healthgen Biotechnology into a list and get an email when it puts out news.
Follow Wuhan Healthgen Biotechnology